<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-viruses-12-00177">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chopineau</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Robert</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fenart</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Cecchelli</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Lagoutte</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Paitier</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Dehouck</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Domurado</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier</article-title>
  <source>J. Control. Release</source>
  <year>1998</year>
  <volume>56</volume>
  <fpage>231</fpage>
  <lpage>237</lpage>
  <pub-id pub-id-type="doi">10.1016/S0168-3659(98)00091-1</pub-id>
  <pub-id pub-id-type="pmid">9801446</pub-id>
 </element-citation>
</ref>
